NOV 24, 2017 10:34 AM PST

Discovery of Compound Provides New Hope for Treating Autoimmune Disease

WRITTEN BY: Kara Marker

The majority of drugs available for people with autoimmune diseases are only designed to alleviate symptoms, as opposed to targeting the root cause of disease. Thanks to the discovery of a new “drug-like compound,” University of Colorado at Boulder scientists believe they can work toward the development of new drugs that target the cause instead of just the symptoms.

Toll-like receptor 2 (TLR2). Credit: European Bioinformatics Institute

The new discovery starts with a component of the innate, or non-specific, immune system called toll-like receptor 8 (TLR8). Upon sensation of a pathogen, TLR8 triggers a domino reaction that changes the receptor from a passive state to an active state. Activate TLR8 releases inflammatory signals that are good for fighting bacteria and viruses, but bad for healthy tissues if the response goes overboard.

Historically, TLR8 has been difficult to study and apply as a drug target because it is “hidden inside the endosome,” while most drug targets are on the cell’s surface. The new CU Boulder study, in an effort to find a molecule to bind TLR8, completed high-throughput screening of more than 14,000 small molecule compounds. Out of the thousands, researchers zeroed in on just four with the potential to have the proper chemical structure for the job.

Using these four small molecules as a model, researchers chemically synthesized their own compound to bind TLR8, preventing TLR8 activity instead of silencing an already-active TLR8. "Before, people were trying to close the open door to shut it down. We found the key to lock the door from the inside so it never opens," explained lead author Hang Hubert Yin.

Yin calls the new synthesized compound and the approach to blocking TLR8 activation “paradigm shifting.”

In the future, Yin and his team plan on continuing their studies of the new TLR8-binding compound and its potential to treat a variety of autoimmune diseases that cause pain, inflammation, and other chronic health issues. Existing drugs can be costly and cause side effects, so the new compound could be the answer for many scientists looking for alternatives.

Yin is planning animal studies and human clinical trials, to learn more about TLR8 and other toll-like receptors.

The present study was published in the journal Nature Chemical Biology.

Source: University of Colorado at Boulder

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 27, 2021
Cell & Molecular Biology
Nanobodies May Prevent Complications From Infection in Transplant Recipents
JUL 27, 2021
Nanobodies May Prevent Complications From Infection in Transplant Recipents
In recent years, scientists java turned their attention to small antibodies that are produced by animals like sharks, ca ...
AUG 30, 2021
Cancer
A Hot Approach to CAR T Cells
AUG 30, 2021
A Hot Approach to CAR T Cells
Immunotherapy, a type of treatment that targets a patient’s immune system to enhance the natural ability to attack ...
AUG 31, 2021
Health & Medicine
People Who Have Had SARS-CoV-2 Infection Have Longer-Lasting Immunity Than Those Who Were Vaccinated Only
AUG 31, 2021
People Who Have Had SARS-CoV-2 Infection Have Longer-Lasting Immunity Than Those Who Were Vaccinated Only
Consider yourself among the luckiest if you made a full recovery from infection with SARS-CoV-2, especially if you were ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
OCT 21, 2021
Immunology
Sunshine Vitamin Boosts Dairy Cows' Immunity
OCT 21, 2021
Sunshine Vitamin Boosts Dairy Cows' Immunity
A new study shows how vitamin D can help dairy cows fend off infections, offering opportunities for better animal health ...
OCT 26, 2021
Immunology
Two Different Arms, Twice the Cancer-Killing Potential?
OCT 26, 2021
Two Different Arms, Twice the Cancer-Killing Potential?
Our immune system has developed an arsenal of sophisticated molecular weapons to defend us against the continuous barrag ...
Loading Comments...